stock is trading at 20 cents. this company put in no effort and put on a 5x target. that isn't negative. its also not a serious start of coverage for NWBO. that is meant to keep retail buying
Agreed. The summary does not really point to why this is a great investment from a potential bounce fairly soon. This also grants one year for the price to reach $1 without mentioning the fact that combo partner interest is going to be piqued once an approval occurs. Many of those potential partners have a looming patent cliff for their checkpoint inhibitors and that will generate an obvious sense of urgency to work out deals because of NWBO’s combo patents that have been granted in many places around the world but not in the U.S. yet. Gee, I wonder why. Big pharma influence maybe? Best wishes.
Market Data 
Markets 
